Key Events This Week
10 Aug: Stock opens at Rs.8,275 with modest gains
11 Aug: New 52-week and all-time high at Rs.8,507.25
12 Aug: Further 52-week high at Rs.8,670.50 amid strong quarterly results
13-14 Aug: Consolidation near Rs.8,500 with mixed market cues

Broad-Based Technical Strength Lifts Divis Laboratories Ltd to 52-Week High of Rs 8670.5
2026-08-12 09:46:08From a 52-week low of Rs 5,637.5 to a fresh peak of Rs 8,670.5, Divis Laboratories Ltd has surged 44.55% over the past year, significantly outperforming the Sensex which declined by 2.75% in the same period. This milestone reflects a sustained rally fuelled by robust technical momentum and a confluence of bullish indicators across multiple timeframes.
Read full news article
Divis Laboratories Ltd Rallies 3.38% and Approaches 52-Week High Amid Broad Market Weakness
2026-08-11 15:17:53While the Sensex declined by 0.5% on 11 Aug 2026, Divis Laboratories Ltd surged 3.38%, touching an intraday high of Rs 8,542. This 3.23% single-session gain stands out as a clear stock-specific event, outperforming its Pharmaceuticals & Biotechnology sector by 2.35 percentage points and signalling strength in an otherwise weak market environment.
Read full news article
Broad-Based Technical Strength Lifts Divis Laboratories Ltd to 52-Week High of Rs 8507.25
2026-08-11 13:10:20With a decisive surge to Rs 8507.25 on 11 Aug 2026, Divis Laboratories Ltd has reached a fresh 52-week and all-time high, marking a 41.68% gain over the past year and outpacing the Sensex’s decline of 3.01% during the same period.
Read full news articleDivis Laboratories Gains 2.38%: 5 Key Factors Driving the Week’s Momentum
2026-08-08 17:09:41
Key Events This Week
3 Aug: New 52-week and all-time high at Rs 8,417.25
3 Aug: Surge in call and put option activity ahead of 25 Aug expiry
4 Aug: High-value trading with strong institutional participation
7 Aug: Week closes at Rs 8,248.50, up 2.38% for the week

Divis Laboratories Ltd is Rated Buy
2026-08-06 10:11:23Divis Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 14 July 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 06 August 2026, providing investors with the latest comprehensive analysis.
Read full news article
Divis Laboratories Ltd Sees High-Value Trading Amid Institutional Interest
2026-08-04 12:00:07Divis Laboratories Ltd, a stalwart in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most actively traded stocks by value on 4 August 2026. Despite a modest intraday decline, the stock’s robust trading volumes and recent upgrade in its Mojo Grade to ‘Buy’ underscore growing institutional confidence and sustained investor interest in this large-cap pharmaceutical leader.
Read full news articleShareholder Meeting / Postal Ballot-Scrutinizers Report
10-Aug-2026 | Source : BSESubmission of Scrutinizers report on 36th AGM resolutions.
Shareholder Meeting / Postal Ballot-Outcome of AGM
10-Aug-2026 | Source : BSEOutcome of 36th AGM - submission of AGM proceedings voting results and Scrutinizers report.
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
06-Aug-2026 | Source : BSESubmission of transcript of Earnings Conference Call held on August 01 2026
Corporate Actions
No Upcoming Board Meetings
Divis Laboratories Ltd has declared 1500% dividend, ex-date: 24 Jul 26
Divis Laboratories Ltd has announced 2:10 stock split, ex-date: 03 Aug 07
Divis Laboratories Ltd has announced 1:1 bonus issue, ex-date: 23 Sep 15
No Rights history available








